Depreciation in USD of Insight Molecular Diagnostics Inc. from 2014 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Insight Molecular Diagnostics Inc. quarterly and annual Depreciation history and change rate from 2014 to Q1 2023.
  • Insight Molecular Diagnostics Inc. Depreciation for the quarter ending 31 Mar 2023 was $450,000, a 57% increase year-over-year.
  • Insight Molecular Diagnostics Inc. annual Depreciation for 2022 was $1,528,000, a 81% increase from 2021.
  • Insight Molecular Diagnostics Inc. annual Depreciation for 2021 was $844,000, a 170% increase from 2020.
  • Insight Molecular Diagnostics Inc. annual Depreciation for 2020 was $313,000, a 9% decline from 2019.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Insight Molecular Diagnostics Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $450,000 +$163,000 +57% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q1 2022 $1,010,000 $287,000 +$166,000 +137% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $844,000 $262,000 +$145,000 +124% 01 Oct 2021 31 Dec 2021 10-K 12 Apr 2023 2022 FY
Q3 2021 $699,000 $255,000 +$186,000 +270% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $513,000 $206,000 +$139,000 +207% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 $374,000 $121,000 +$61,000 +102% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $313,000 $117,000 +$51,000 +77% 01 Oct 2020 31 Dec 2020 10-K 11 Mar 2022 2021 FY
Q3 2020 $262,000 $69,000 -$15,000 -18% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $277,000 $67,000 -$17,000 -20% 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021 2021 Q2
Q1 2020 $294,000 $60,000 -$50,000 -45% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q4 2019 $344,000 $66,000 -$55,000 -45% 01 Oct 2019 31 Dec 2019 10-K 19 Mar 2021 2020 FY
Q3 2019 $399,000 $84,000 -$26,000 -24% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 $425,000 $84,000 -$20,000 -19% 01 Apr 2019 30 Jun 2019 10-Q 29 Jul 2020 2020 Q2
Q1 2019 $445,000 $110,000 +$7,000 +6.8% 01 Jan 2019 31 Mar 2019 10-Q 12 May 2020 2020 Q1
Q4 2018 $438,000 $121,000 +$20,000 +20% 01 Oct 2018 31 Dec 2018 10-K 26 Mar 2020 2019 FY
Q3 2018 $418,000 $110,000 +$17,000 +18% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2019 Q3
Q2 2018 $401,000 $104,000 +$27,000 +35% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019 2019 Q2
Q1 2018 $374,000 $103,000 +$36,000 +54% 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019 2019 Q1
Q4 2017 $338,000 $101,000 01 Oct 2017 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2017 $93,000 +$45,000 +94% 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018 2018 Q3
Q2 2017 $77,000 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q1 2017 $67,000 +$57,000 +570% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q3 2016 $48,000 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017 2017 Q3
Q1 2016 $10,000 -$1,000 -9.1% 01 Jan 2016 31 Mar 2016 10-Q 28 Apr 2017 2017 Q1
Q1 2015 $11,000 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016 2016 Q1

Insight Molecular Diagnostics Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $1,528,000 +$684,000 +81% 01 Jan 2022 31 Dec 2022 10-K 12 Apr 2023 2022 FY
2021 $844,000 +$531,000 +170% 01 Jan 2021 31 Dec 2021 10-K 12 Apr 2023 2022 FY
2020 $313,000 -$31,000 -9% 01 Jan 2020 31 Dec 2020 10-K 11 Mar 2022 2021 FY
2019 $344,000 -$94,000 -21% 01 Jan 2019 31 Dec 2019 10-K 19 Mar 2021 2020 FY
2018 $438,000 +$100,000 +30% 01 Jan 2018 31 Dec 2018 10-K 26 Mar 2020 2019 FY
2017 $338,000 +$193,000 +133% 01 Jan 2017 31 Dec 2017 10-K 01 Apr 2019 2018 FY
2016 $145,000 +$104,000 +254% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
2015 $41,000 +$2,000 +5.1% 01 Jan 2015 31 Dec 2015 10-K 02 Apr 2018 2017 FY
2014 $39,000 01 Jan 2014 31 Dec 2014 10-K 27 Feb 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.